Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
TV & Film
Sports
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/c5/a1/2d/c5a12d34-6c60-b471-9966-f8b710349446/mza_13630754953206138230.png/600x600bb.jpg
Treating Blood Cancers
Blood Cancer United
106 episodes
1 week ago
Blood cancers are complex and multifaceted diseases, requiring knowledge by healthcare professionals on the array of diagnostic tests, treatment therapies, and survivorship issues. The Podcast Series for Professionals provides up to date and accurate information on diagnosis, treatment and survivorship to educate HCPs treating patients with blood cancer. Listen in as we speak with experts who will guide us in understanding these topics, as well as address the importance of clinical trials, side effects management, and other concerns.
Show more...
Medicine
Education,
Health & Fitness,
Science,
Natural Sciences
RSS
All content for Treating Blood Cancers is the property of Blood Cancer United and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Blood cancers are complex and multifaceted diseases, requiring knowledge by healthcare professionals on the array of diagnostic tests, treatment therapies, and survivorship issues. The Podcast Series for Professionals provides up to date and accurate information on diagnosis, treatment and survivorship to educate HCPs treating patients with blood cancer. Listen in as we speak with experts who will guide us in understanding these topics, as well as address the importance of clinical trials, side effects management, and other concerns.
Show more...
Medicine
Education,
Health & Fitness,
Science,
Natural Sciences
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/c5/a1/2d/c5a12d34-6c60-b471-9966-f8b710349446/mza_13630754953206138230.png/600x600bb.jpg
Decoding Medicare for Healthcare Professionals
Treating Blood Cancers
35 minutes 19 seconds
1 year ago
Decoding Medicare for Healthcare Professionals





Stacie B. Dusetzina, PhD, Vanderbilt University Medical Center, Nashville, TN and Bethany Lilly, JD, The Leukemia & Lymphoma Society, Rye Brook, NY







Recorded on September 20, 2024



Tune in to this informative episode as Dr. Stacie Dusetzina from Vanderbilt University and Bethany Lilly from The Leukemia & Lymphoma Society’s Office of Public Policy simplify the complexities of Medicare, and how healthcare professionals can help their patients navigate these decisions for better care outcomes. They discuss how plan choices affect access to cancer treatment and the financial burden of high-cost medications. They also examine the recent changes brought by the Inflation Reduction Act and what they mean for Medicare beneficiaries. Listen today to learn more about helping your patients make informed decisions, including helpful resources, in this important aspect of healthcare!






Stacie B. Dusetzina, PhD
Professor, Health Policy
Ingram Professor of Cancer Research
Vanderbilt University Medical Center
Nashville, TN









Bethany Lilly, JD
Executive Director, Public Policy
The Leukemia & Lymphoma Society
Rye Brook, NY








Resources mentioned in this episode:




* American Cancer Society



* Centers for Medicare and Medicaid Services



* Medicare Plan Finder



* State Health Insurance Assistance Program (SHIP)



* The Leukemia & Lymphoma Society



* Triage Cancer







Treating Blood Cancers
Blood cancers are complex and multifaceted diseases, requiring knowledge by healthcare professionals on the array of diagnostic tests, treatment therapies, and survivorship issues. The Podcast Series for Professionals provides up to date and accurate information on diagnosis, treatment and survivorship to educate HCPs treating patients with blood cancer. Listen in as we speak with experts who will guide us in understanding these topics, as well as address the importance of clinical trials, side effects management, and other concerns.